Sensus Healthcare Inc. (SRTS)

$3.26

up-down-arrow $-0.08 (-2.25%)

As on 02-Sep-2026 12:30EDT

Market cap

info icon

$58 Mln

Revenue (TTM)

info icon

$18 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.5

Div. Yield

info icon

0 %

Sensus Healthcare (SRTS) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 3.22 High: 3.38

52 Week Range

Low: 2.66 High: 5.49

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -0.3 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    44.46

  • EV/EBITDAEV/EBITDA information

    8.7

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-0.9

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    16,462,059

10 Years Aggregate

CFO

$-22.06 Mln

EBITDA

$-0.45 Mln

Net Profit

$12.96 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Sensus Healthcare (SRTS)
-18.2 11.9 14.2 -4.0 1.4 -1.9 -6.4
BSE Sensex
-9.6 -2.0 3.1 -4.7 5.4 6.0 10.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 02-Sep-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
2020
2019
Sensus Healthcare (SRTS)
-42.5 190.7 -68.2 2.8 87.0 9.0 -52.2
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3 9.6 20.9
BSE Sensex
9.1 8.1 18.7 4.4 22.0 15.8 14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Sensus Healthcare (SRTS)
3.3 58.0 17.5 -15.5 -56.5 -36.5 -- 1.5
60.2 8,018.1 616.9 -75.1 1.7 -9.3 -- 10.2
14.6 9,638.1 6,561.1 -578.0 -4.5 -10.3 -- 1.7
365.1 9,761.6 2,589.3 222.4 -6.0 3 44.5 1.3
58.4 8,696.7 3,499.6 -71.2 0.5 -3.2 -- 3.8
179.0 10,905.5 612.8 -188.1 -30.6 -28.1 -- 16.4
100.9 6,577.5 1,556.3 275.3 24.6 22.9 24.1 5.0
91.0 5,403.2 1,579.2 145.6 14.3 8.9 37.2 3.2
324.2 12,752.7 1,504.9 160.6 13.6 10.9 79.4 8.4
172.3 9,947.9 785.1 41.5 9.9 2 251.8 4.9

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Sensus Healthcare (SRTS)

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of...  treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida. 

  • Co-Founder, Chairman & CEO

    Mr. Joseph C. Sardano

  • Co-Founder, Chairman & CEO

    Mr. Joseph C. Sardano

  • Headquarters

    Boca Raton, FL

  • Website

    https://sensushealthcare.com

FAQs for Sensus Healthcare (SRTS)

The share price of Sensus Healthcare Inc (SRTS) is $3.26 (NASDAQ) as of 02-Sep-2026 12:30 EDT. Sensus Healthcare Inc (SRTS) has given a return of 1.42% in the last 3 years.

Since, TTM earnings of Sensus Healthcare Inc (SRTS) is negative, P/E ratio is not available.
The P/B ratio of Sensus Healthcare Inc (SRTS) is 1.52 times as on 28-Aug-2026, a 60 discount to its peers’ median range of 3.79 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-8.42
1.35
2024
17.12
2.04
2023
79.17
0.79
2022
5.07
2.56
2021
29.10
4.61

The 52-week high and low of Sensus Healthcare Inc (SRTS) are Rs 5.49 and Rs 2.66 as of 02-Sep-2026.

Sensus Healthcare Inc (SRTS) has a market capitalisation of $ 58 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Sensus Healthcare Inc (SRTS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...